Pereiti į pagrindinį turinį
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Apie mus 
      • Novartis Lietuvoje 
      • Strategija 
      • Įvairovė ir įtrauktis 
      • Žmonės ir kultūra 
      • Produktai 
      • Susisiekite su mumis 
      Apie mus
      Apie mus
    • Pacientai ir slaugytojai 
      • Novartis įsipareigojimas pacientams ir slaugytojams 
      • Ligos 
      • Produktai 
      • Pranešti apie nepageidaujamą reiškinį 
        • Pranešti apie įtariamą nepageidaujamą reiškinį 
      • Parama pacientų organizacijoms 
      Pacientai ir slaugytojai
    • Sveikatos priežiūros specialistai 
      • Novartis interneto svetainė sveikatos priežiūros specialistams 
      • Produktai 
      • Novartis vystomų produktų asortimentas 
      • Pranešti apie nepageidaujamą reiškinį 
      • Bendradarbiavimas su sveikatos priežiūros specialistais 
      • Novartis klinikiniai tyrimai 
      Gydytojai kalbasi ligonineje
      Sveikatos priežiūros specialistai
    • Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV) 
      • Etika, rizikos valdymas ir atitiktis 
      • Prieinamumas 
      • Aplinkos tvarumas 
      • Pasaulinė sveikatos apsauga 
      • Etiškas elgesys 
        • Etikos kodeksas 
      Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV)
      Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV)
    • Naujienos 
      • Naujienų archyvas 
      • Susisiekite su mumis 
      A photo of people in a meeting hall
      Naujienos
    • Karjera 
      • Karjeros paieška 
      • Mūsų komandos 
      • Asmeninis augimas 
      • Jaunieji talentai 
      • Kaip mes dirbame 
      • Darbuotojų gerovė 
      • Įvairovė ir įtrauktis 
      • Apdovanojimai ir pripažinimas 
      Karjera
      Karjera
    • Koronavirusas 
      Koronavirusas
      Koronavirusas
    Lietuvos ofisas
    Pagrindinis puslapis
  1. Pagrindinis puslapis
  2. Karjeros paieška
  3. Karjeros paieška
  • Sort by Sort ascending
  • Darbo pavadinimas Sort ascending
  • Svetainė
  • Vieta
  • Padalinys
  • Veikla
  • Functional Area
  • Paskelbimo data
Darbo pavadinimas Sort ascending Svetainė Vieta Padalinys Veikla Functional Area Paskelbimo data
Medical Manager Budapest Hungary International Innovative Medicines Research & Development Geg 23, 2025
Medical Device Testing Laboratory Associate (m/f/d) Schaftenau Austria Development Innovative Medicines Research & Development Geg 23, 2025
Principal Scientist I, In Vivo Pharmacology (Echocardiography) – CVM Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Geg 23, 2025
Associate Director Biomarker Lead London (The Westworks) United Kingdom Biomedical Research Universal Hierarchy Node Research & Development Geg 23, 2025
Medical Science Liaison (MSL) Allergy Dermatology No. CA / No. NV - Remote Field Non-Sales (USA) USA US Universal Hierarchy Node Research & Development Geg 23, 2025
Vodja projektov za farmacevtske izdelke (m/ž/d) / Drug Product Project Lead (m/f/d) Mengeš Slovenia Development Innovative Medicines Research & Development Geg 23, 2025
Associate Director, xRNA Therapeutics Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Geg 23, 2025
Medical Science Liaison (MSL), Cardiovascular - Hartford, CT - Remote Field Non-Sales (USA) USA US Universal Hierarchy Node Research & Development Geg 23, 2025
Associate Director, Statistical Programming Dublin (NOCC) Ireland Development Innovative Medicines Research & Development Geg 23, 2025
Expert Biostatisticien & Data manager H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Universal Hierarchy Node Research & Development Geg 23, 2025
Principal Biostatistician East Hanover USA Development Innovative Medicines Research & Development Geg 23, 2025
Medical Science Liaison (MSL) Cardiometabolic So. NV / UT / No. AZ - Remote Field Non-Sales (USA) USA US Universal Hierarchy Node Research & Development Geg 23, 2025
Associate Director Biostatistics East Hanover USA Development Innovative Medicines Research & Development Geg 23, 2025
Coordinateur Etudes Locales H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Universal Hierarchy Node Research & Development Geg 23, 2025
Sr. Field Medical Lead (MSL) - Imunologia - São Paulo Santo Amaro Brazil International Innovative Medicines Research & Development Geg 23, 2025
Sr. Field Medical Lead (MSL) - Imunologia - Rio de Janeiro Santo Amaro Brazil International Innovative Medicines Research & Development Geg 23, 2025
Global Clinical Supply Japan Toranomon (NPKK Head Office) Japan Development Universal Hierarchy Node Research & Development Geg 23, 2025
Manager, GCS Japan Toranomon (NPKK Head Office) Japan Development Universal Hierarchy Node Research & Development Geg 23, 2025
Principal Developer, Technology and Scientific Computing Hyderabad (Office) India Development Innovative Medicines Research & Development Geg 22, 2025
(Sr) Medical Advisor-RLT Shanghai (Shanghai) China International Innovative Medicines Research & Development Geg 22, 2025
MSL or Senior MSL Immunology - East of England to Sheffield Field Force (England / Wales) United Kingdom International Universal Hierarchy Node Research & Development Geg 22, 2025
Senior Expert Science & Technology (GxP & Compliance) Telangana India Development Innovative Medicines Research & Development Geg 22, 2025
Senior Principal Scientist – siRNA Chemistry Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Geg 22, 2025
Senior Expert Science & Technology – Data Science in Downstream Process Development Schaftenau Austria Development Innovative Medicines Research & Development Geg 22, 2025
Expert Science & Technology – Analytical Characterization of Biopharmaceuticals Kundl Austria Development Innovative Medicines Research & Development Geg 22, 2025
Strategy & Engagement Director Dublin (NOCC) Ireland Development Innovative Medicines Research & Development Geg 22, 2025
Medical Science Liaison (MSL) Nephrology - MI and OH - Remote Field Non-Sales (USA) USA US Universal Hierarchy Node Research & Development Geg 22, 2025
Medical Science Liaison (MSL) Cardiometabolic Oklahoma / West Texas - Remote Field Non-Sales (USA) USA US Universal Hierarchy Node Research & Development Geg 22, 2025
Global Program Clinical Head East Hanover USA Development Innovative Medicines Research & Development Geg 22, 2025
Hematology MSL Seoul South Korea International Innovative Medicines Research & Development Geg 22, 2025
Medical Science Liaison, Immunology Guangzhou (Guangdong Province) China International Innovative Medicines Research & Development Geg 22, 2025
CTSM Hyderabad (Office) India Development Innovative Medicines Research & Development Geg 21, 2025
Clinical Program Leader Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Geg 21, 2025
Medical Director/Senior Medical Director, Prostate Cancer/GU RLT, US Medical Affairs Remote Position (USA) USA US Universal Hierarchy Node Research & Development Geg 21, 2025
Senior Principal Clinical Data Scientist Dublin (NOCC) Ireland Development Innovative Medicines Research & Development Geg 21, 2025
Clinical Research Associate Amsterdam Netherlands Development Innovative Medicines Research & Development Geg 21, 2025
Senior Study Leader East Hanover (New Jersey) USA Development Innovative Medicines Research & Development Geg 21, 2025
Medical Science Liaison - Hematology- HaNoi Vietnam Vietnam International Universal Hierarchy Node Research & Development Geg 21, 2025
Senior Expert Science & Technology (m/f/d) Schaftenau Austria Development Innovative Medicines Research & Development Geg 21, 2025
Global Program Associate Director London (The Westworks) United Kingdom Development Universal Hierarchy Node Research & Development Geg 21, 2025
*Senior Clinical Development Director - Renal Basel (City) Switzerland Development Innovative Medicines Research & Development Geg 21, 2025
MSL or Senior MSL Immunology - South West England & Wales Field Force (England / Wales) United Kingdom International Universal Hierarchy Node Research & Development Geg 21, 2025
Senior Expert or Associate Director CMC Statistics East Hanover USA Development Innovative Medicines Research & Development Geg 21, 2025
Associate Director Science & Technology (m/f/d) Schaftenau Austria Development Innovative Medicines Research & Development Geg 21, 2025
Clinical Trial Associate (CTA) - Vaga exclusiva PCD Santo Amaro Brazil Development Innovative Medicines Research & Development Geg 21, 2025
Associate Director, PK Sciences Neuroscience Therapeutic Area Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Geg 21, 2025
Senior Study Leader Toranomon (NPKK Head Office) Japan Development Universal Hierarchy Node Research & Development Geg 21, 2025
Senior Clinical Development Medical Director - Renal Basel (City) Switzerland Development Innovative Medicines Research & Development Geg 20, 2025
Physician Scientist, Diseases of Aging and Regenerative Medicine (DARe) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Geg 20, 2025
Medical Lead Kerala India International Innovative Medicines Research & Development Geg 20, 2025

Pagination

  • ‹ Ankstesnis puslapis
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 10
  • › Next page

Novartis Lietuvoje

Naršyti Novartis svetainėje
  • Pacientai ir slaugytojai
  • Sveikatos priežiūros specialistai
  • Kompanijos etika
  • Naujienos
  • Karjera
Naujienos
  • Naujienų archyvas
Mūsų portfelis
  • Novartis vystomų produktų asortimentas
  • Novartis produktai
Kitos Novartis svetainės
  • Pasaulinė svetainė
Footer Bottom
© 2025 Novartis AG
  • Privatumo politika
  • Naudojimo sąlygos
  • Slapukai
  • Slapukų nustatymai
  • Svetainės schema
  • Svetainės prieinamumas
Novartis svetainių katalogas
Ši svetainė skirta Lietuvos gyventojams